Merck Frosst
Patients & Caregivers Contact Us Français
Patients & CaregiversContact UsFrançais
Home

PrHYZAAR® / PrHYZAAR DS

(losartan potassium and hydrochlorothiazide tablets)

Disclaimer

Tablet image and Packaging change

 Tablet image change - Visual Download
 Packaging change - Visual Download
 Changes Summary Download

Original Notice of Compliance (NoC)

HYZAAR®: October 30, 1995

Therapeutic / Pharmacological Classification

Angiotensin II Receptor Antagonist and Diuretic

Product Monograph / Prescribing Information / Product Information

Download  

Date of revision: October 3, 2008 (08, 10-a_122645)
File name: HYZAAR_0810-a_122645-E.pdf
File size: 161 KB

CONSUMER INFORMATION

Download   Date of revision: October 3, 2008 (08, 10-a_122645)
File name: HYZAAR_0810-a_122645-CI-E.pdf
File size: 47 KB


This file is presented in PDF format.  This software is available at no charge through the Adobe Web site.  Get Adobe Reader

DISCLAIMER
The contents of this site, including but not limited to Merck Frosst product information and product monographs, are for informational purposes only and are intended solely for residents of Canada, and are not intended, nor should they be used, as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician, pharmacist or other qualified health care provider with any questions you may have regarding a medical condition.


® Registered Trademark of Merck & Co., Inc. Used under license.

Printer friendly
Email a friend

This site is for residents of Canada. / This site was updated on December 11th, 2008.